Home › Funds › Elmind Capital, LP › ENGN
Elmind Capital, LP position in ENGN
ENGENE THERAPEUTICS INC · Health Care
Elmind Capital, LP reported holding 210,000 shares of ENGN (ENGENE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$363K, representing 0.09% of its reported portfolio and ranking #35 among its reported holdings. Elmind Capital, LP has disclosed ENGN holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Elmind Capital, LP's ENGN position evolved
Elmind Capital, LP first disclosed a stake in ENGN in Q4 2025 at 210,000 shares (US$1.9M). Across 3 filings, Elmind Capital, LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 210,000 shares valued at US$363K.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 210.00K | $1.90M | New |
| Q1 2026 | 210.00K | $1.43M | Hold |
| Q2 2026 | 210.00K | $363.30K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ENGN and 13F data
ENGN (ENGENE THERAPEUTICS INC) is a Health Care company. 32 other funds we track also report a position in ENGN — the largest reported positions include FCPM III SERVICES B.V. (US$16.7M), BML Capital Management, LLC (US$11.5M), Nextech Invest Ltd. (US$4.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ENGN
- FCPM III SERVICES B.V. 9.63M sh · $16.66M · Q2 2026
- BML Capital Management, LLC 6.67M sh · $11.54M · Q2 2026
- Nextech Invest Ltd. 2.32M sh · $4.02M · Q2 2026
- ACORN CAPITAL ADVISORS, LLC 1.27M sh · $2.20M · Q2 2026
- Peapod Lane Capital LLC 1.04M sh · $2.08M · Q3 2026
- Omega Fund Management, LLC 876.36K sh · $1.52M · Q2 2026
- SR ONE CAPITAL MANAGEMENT, LP 747.75K sh · $1.29M · Q2 2026
- Kynam Capital Management, LP 457.86K sh · $792.09K · Q2 2026
More on Elmind Capital, LP
FAQ
How long has Elmind Capital, LP held ENGN?
Elmind Capital, LP has disclosed ENGN holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is Elmind Capital, LP's current position in ENGN?
As of Q2 2026, Elmind Capital, LP holds 210.00K shares of ENGN (ENGENE THERAPEUTICS INC), valued at $363.30K, representing 0.09% of its reported portfolio and ranking #35.
Has Elmind Capital, LP been buying or selling ENGN?
In the latest 13F filing (Q2 2026), Elmind Capital, LP held unchanged its position in ENGN.
Which other funds hold ENGN?
Other major institutional holders of ENGN include FCPM III SERVICES B.V., BML Capital Management, LLC, Nextech Invest Ltd., among 32 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.